Search

Pages

1. • Journal article

   • 

   Acute renal failure as the first presenting sign of non-Hodgkin's lymphoma.

   Krug, Bruno[UCL] Willemart, B. Mathieu, I Pirson, Anne-Sophie[UCL] Luyx, D Sonet, Anne Bosly, André[UCL] Vander Borght, Thierry[UCL] (2004) European journal of nuclear medicine and molecular imaging — Vol. 31, no. 4, p. 613 (2004)
2. • Journal article

   • 

   Rituximab in B-cell disorders other than non-Hodgkin's lymphoma.

   Bosly, André[UCL] Keating, Michael J Stasi, Roberto Bradstock, Ken (2002) Anti-cancer drugs — Vol. 13 Suppl 2, p. S25-33 (2002)
3. • Journal article

   • 

   Lymphomes diffus à grandes cellules B

   Bosly, André[UCL] Fervaille, Caroline[UCL] Antoine-Poirel, H Michaux, D (2023) EMC - Hématologie — Vol. 34, no.1 (2023)
4. • Journal article

   • 

   Myelodysplastic syndrome with monosomy 5 and/or 7 following therapy with 2-chloro-2'-deoxyadenosine.

   Van Den Neste, Eric[UCL] Louviaux, I Michaux, Jean-Louis[UCL] Delannoy, André[UCL] Michaux, Lucienne[UCL] Hagemeijer, Anne[UCL] Scheiff, Jean-Marie[UCL] Bosly, André[UCL] Straetmans, Nicole[UCL] Ferrant, Augustin[UCL] (1999) British journal of haematology — Vol. 105, no. 1, p. 268-70 (1999)
5. • Journal article

   • 

   Quantification of CD34+ cells mobilized into the peripheral blood predicts the yield of the leukapheresis product and can replace progenitor assays

   D'Hondt, Lionel[UCL] André, Marc[UCL] Guillaume, Thierry[UCL] Feyens, Anne Marie[UCL] Humblet, Yves[UCL] Doyen, Chantal[UCL] Bosly, André[UCL] Dromelet, Alex[UCL] Chatelain, Bernard[UCL] Symann, Michel[UCL] (1997) Cytokines, Cellular & Molecular Therapy (Print) — Vol. 3, no. 1, p. 21-26 (1997)
6. • Journal article

   • 

   Phase-ii Clinical-trials With Vindesine in Patients With Hematologic Malignancies

   Mathe, G. Ferrant, Augustin[UCL] Hulhoven, R. Sokal, G. Bayssas, M. Belpomme, D. Bosly, André[UCL] Cornu, Guy[UCL] Delannoy, André[UCL] Deluca, L. Devassal, F. Gouveia, J. Hayat, M. Jasmin, C. Machover, D. Michaux, JL. Misset, JL. Musset, M. Pico, JL. Ribaud, P. Schwartzenberg, L. (1981) Anticancer Research : international journal of cancer research and treatment — Vol. 1, no. 1, p. 1-9 (1981)
7. • Journal article

   • 

   Limited activity of mini-dose interferon alpha-2a in the treatment of myelodysplastic syndrome.

   Maerevoet, Marie Van Den Neste, Eric[UCL] Delannoy, André[UCL] Ferrant, Augustin[UCL] Martiat, P. Bosly, André[UCL] Fauchet, M Michaux, Jean-Louis[UCL] (1996) Leukemia & lymphoma — Vol. 21, no. 5-6, p. 519-20 (1996)
8. • Journal article

   • 

   Clinical and pathological features of 14 non-Hodgkin's lymphomas associated with coeliac disease.

   Sonet, Anne Théate, Ivan[UCL] Delos, Monique[UCL] Montfort, L. Mineur, P. Driesschaert, P. Michaux, Lucienne[UCL] Ferrant, Augustin[UCL] Bosly, André[UCL] (2004) Acta clinica Belgica — Vol. 59, no. 3, p. 143-51 (2004)
9. • Journal article

   • 

   Evaluation of a low density DNA microarray for small B-cell non-Hodgkin lymphoma differential diagnosis.

   Gillet, Jean-Pierre Molina, Thierry Jo Jamart, Jacques[UCL] Gaulard, Philippe Leroy, Karen Briere, Josette Theate, Ivan Thieblemont, Catherine Bosly, André[UCL] Herin, Michel Hamels, Jacques Remacle, Jose (2009) Leukemia and Lymphoma — Vol. 50, no. 3, p. 410-418 (2009)
10. • Journal article

    • 

    Acute leukaemia in paroxysmal nocturnal haemoglobinuria. Case report and review of the literature.

    Cornelis, Frank[UCL] Montfort, Luc[UCL] Osselaer, Jean-Claude[UCL] Sonet, Anne[UCL] Doyen, Chantal[UCL] Chatelain, Christian[UCL] Chatelain, Bernard[UCL] Bosly, André[UCL] (1996) Hematology and Cell Therapy — Vol. 38, no. 3, p. 285-288 (1996)
11. • Journal article

    • 

    Nodular, Lymphocyte-Predominant Hodgkin Lymphoma A Long-Term Study and Analysis of Transformation to Diffuse Large B-Cell Lymphoma in a Cohort of 164 Patients From the Adult Lymphoma Study Group

    Biasoli, Irene Stamatoullas, Aspasia Meignin, Veronique Delmer, Alain Reman, Oumedaly Morschhauser, Franck Coiffier, Bertrand Bosly, André[UCL] Divine, Marine Brice, Pauline (2010) Cancer — Vol. 116, no. 3, p. 631-9 (2010)
12. • Journal article

    • 

    Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma.

    Villa, Diego Hoster, Eva Hermine, Olivier Klapper, Wolfram Szymczyk, Michal Bosly, André[UCL] Unterhalt, Michael Rimsza, Lisa M Ramsower, Colleen Freeman, Ciara L Scott, David W Gerrie, Alina S Savage, Kerry J Sehn, Laurie H Dreyling, Martin (2022) Blood advances — Vol. 6, no. 18, p. 5285-5294 (2022)
13. • Journal article

    • 

    (90)Y ibritumomab tiuxetan (Zevalin) combined with BEAM (Z -BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory low-grade CD20-positive B-cell lymphoma. A GELA phase II prospective study.

    Decaudin, Didier Mounier, Nicolas Tilly, Hervé Ribrag, Vincent Ghesquières, Hervé Bouabdallah, Krimo Morschhauser, Franck Coiffier, Bertrand Le Gouill, Steven Bologna, Serge Delarue, Richard Huynh, Anne Bosly, André[UCL] Brière, Josette Gisselbrecht, Christian (2011) Clinical lymphoma, myeloma & leukemia — Vol. 11, no. 2, p. 212-8 (2011)
14. • Speech

    • 

    90yttrium Ibritumomab Tiuxetan (zevalin) Combined With Beam (z-beam) Conditioning Regimen Plus Autologous Stem Cell Transplantation in Relapsed Or Refractory Follicular Lymphoma. a Gela Phase Ii Prospective Study

    Gisselbrecht, C. Decaudin, D. Mounier, N. Tilly, H. Ribrag, V. Sebban, C. Milpied, N. Morschhauser, F. Coiffier, B. Le Gouill, S. Lederlin, P. Delarue, R. Laurent, Gabrielle[UCL] Bosly, André[UCL] (2009) 14th Annual Meeting of the European-Hematology-Association — Berlin(Germany)
15. • Speech

    • 

    SGN-30 (Anti-CD30 monoclonal antibody) is active and well tolerated in patients with refractory or recurrent systemic anaplastic large cell lymphoma (ALCL)

    Forero-Torres, A Bernstein, SH Gopal, AK Foss, F Leonard, JP. Rosenblatt, JD Bartlett, NL Cheson, BD Epner, E Hernandez-Illizaliturri, FJ Proctor, SJ Brice, P. Tilly, H. Haioun, C. Jerkeman, M Bosly, André[UCL] Lorenz, JM Barton, J (2005) 47th Annual Meeting of the American-Society-of-Hematology — Atlanta(Ga)
16. • Journal article

    • 

    Évaluation du PET/CT en fin de traitement à l’ère du PET/CT précoce dans le lymphome de Hodgkin classique en traitement de première ligne

    Bodart, Fiona[UCL] André, Marc[UCL] Bosly, André[UCL] (2019) Louvain médical — Vol. 138, no. 09, p. 569-570 (2020)
17. • Journal article

    • 

    Low-dose 5-aza-2 '-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: A multicenter phase II study in elderly patients

    Wijermans, P Ferrant, Augustin[UCL] Lubbert, M Verhoef, G. Bosly, André[UCL] Ravoet, C André, Marc (2000) Journal of Clinical Oncology — Vol. 18, no. 5, p. 956-962 (2000)
18. • Speech

    • 

    Complete Response After High-Dose Methotrexate-Based Chemotherapy as a Major Prognostic Factor for Primary CNS Lymphoma: An Exploratory Analysis of the LNHCP93 Trial of the Groupe d'Etude Des Lymphomes De l'Adulte

    Ghesquieres, Herve Van Den Neste, Eric[UCL] Ferlay, Celine Bajard, Agathe Sebban, Catherine Perol, David Bosly, André[UCL] Casasnovas, Olivier Reman, Oumedaly Coiffier, Bertrand Tilly, Herve Morel, Pierre De Prijck, Bernard Colin, Philippe Ketterer, Nicolas Antoine, Thyss Delannoy, Andre Haioun, Corinne Devidas, Alain Biron, Pierre Blay, Jean-Yves (2009) 51st Annual Meeting of the American-Society-of-Hematology — New Orleans (La)
19. • Journal article

    • 

    Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2 '-deoxycytidine

    Lubbert, M Ferrant, Augustin[UCL] Wijermans, P Kunzmann, R Verhoef, G. Bosly, André[UCL] Ravoet, C André, Marc (2001) British Journal of Haematology — Vol. 114, no. 2, p. 349-357 (2001)
20. • Speech

    • 

    DNA demethylating therapy in MDS: The experience with 5-AZA-2 '-deoxycytidine (decitabine).

    Wijermans, P Ferrant, Augustin[UCL] Luebbert, M Verhoef, G. Bosly, André[UCL] Ravoet, C André, Marc Haak, H (1999) —
21. • Speech

    • 

    Superiority of late over early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma: A randomized study from the GELA: LNH RP 93.

    Bosly, André[UCL] Sonet, Anne Salles, G. Brice, P. Haioun, C. Kerneis, Y Tilly, H. Lederlin, P. Plantier, I Sebban, C. Gisselbrecht, C. Coiffier, B. (1997) —
22. • Speech

    • 

    2-Chlorodeoxyadenosine (CDA) therapy in chronic lymphocytic leukemia (CLL) and Waldenstrom's macroglobulinemia (WD): An update on 77 patients.

    Maerevoet, M. Ferrant, Augustin[UCL] Delannoy, André[UCL] Bosly, André[UCL] Martiat, P. Mineur, P. Canon, JL. Zenebergh, A. Michaux, JL. (1995) —
23. • Speech

    • 

    De novo AML M4Eo with t(3;21)(q26;q22) and AML-MDS/EVI-1 fusion transcript.

    Jost, E Michaux, Lucienne[UCL] Ferrant, Augustin[UCL] Sonet, Anne Chatelain, Bernard Doyen, Chantal Vaerman, JL. Bosly, André[UCL] (1999) —
24. • Speech

    • 

    Superiority of late over early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma: A randomized study from the GELA: LNH RP 93.

    Bosly, André[UCL] Ferrant, Augustin[UCL] Sonet, Anne Salles, G. Brice, P. Haioun, C. Kerneis, Y Tilly, H. Lederlin, P. Plantier, I Sebban, C. Gisselbrecht, C. Coiffier, B. (1998) —
25. • Journal article

    • 

    A phase II study of vindesine in patients with hematological malignancies.

    Hulhoven, R. Michaux, Jean-Louis[UCL] Cornu, Guy[UCL] Ferrant, Augustin[UCL] Bosly, André[UCL] Delannoy, André[UCL] Sokal, G. (1980) Biomedicine / [publiée pour l'A.A.I.C.I.G.] — Vol. 33, no. 2, p. 31-2 (1980)

Pages